Michael Cruse

Michael Cruse, Senior Vice President of Corporate Operations

Michael is the Senior Vice President of Corporate Operations of Reneo Pharmaceuticals, where he brings more than 20 years of experience in corporation operations and business administration. Prior to joining Reneo, Michael was Novus Therapeutics’ (now Eledon Pharmaceuticals) Vice President of Corporate Operations, where he oversaw the daily non-finance general and administrative operations.

Michael previously served as the Vice President of Corporate Operations at OticPharma, Inc (acquired by Tokai Pharmaceuticals) and the Executive Director of Sales Operations at Avanir Pharmaceuticals (acquired by Otsuka Pharmaceuticals.) Earlier in his career, he co-founded a technology consulting firm focused on bringing technology platforms and business automation to small and mid-market organizations. Michael holds a Bachelor of Science in Business Administration from Franklin University.